Impressive to see Lilly launch LillyPod, the first NVIDIA DGX SuperPOD with DGX B300 systems. Is it even possible to compete in this space anymore? My experience launching startups and programs says yes, if you lean into startup advantages: pick a narrow, clinically meaningful problem you can validate fast; secure or partner for unique data and domain workflows; design pilots that align with regulatory and procurement paths. If you are building in this space, send me a message. #AIinPharma
https://blogs.nvidia.com/blog/lilly-ai-factory-live/ …more
Enterprise AI
Work by Michael Ashley · Everyone on Enterprise AI
Channel names and logos are trademarks of their respective owners.